Congenital Heart Disease Intervention, An Issue of Interventional Cardiology Clinics
Levi· ISBN 9780323654999
Special offer terms
Zookal Study Premium
Subscribe & save
By selecting the 'Susbcribe & Save' option you are enrolling in an auto-renewing subscription of Zookal Study Premium. Cancel at anytime.
Auto-Renewal
Your Zookal Study Premium subscription will be renewed each month until you cancel. You consent to Zookal automatically charging your payment method on file $19.99 each month after 1st month free period until you cancel.
How to Cancel
You can cancel your subscription anytime by visiting Manage account page, clicking "Manage subscription" and completing the steps to cancel. Cancellations take effect at the end of the 1st month free period (if applicable) or at the end of the current billing cycle in which your request to cancel was received. Subscription fees are not refundable.
Zookal Study Premium Monthly Subscription Includes:
Ability to post up to ten (10) questions per month.
20% off your textbooks order and free standard shipping whenever you shop online at
textbooks.zookal.com.au
Unused monthly subscription benefits have no cash value, are not transferable, and expire at the end of each month. This means that subscription benefits do not roll over to or accumulate for use in subsequent months.
Payment Methods
Afterpay and Zip Pay will not be available for purchases with Zookal Study Premium subscription added to bag.
$1.00 preauthorisation
You may see a $1.00 preauthorisation by your bank which will disappear from your statement in a few business days..
Email communications
By adding Zookal Study Premium, you agree to receive email communications from Zookal.
Guest edited by Dr. Daniel Levi, this issue of Interventional Cardiology Clinics will cover several key areas of interest related to Congenital Heart Disease Intervention. This issue is one of four selected each year by our series Editor-in-Chief, Dr. Matthew Price of Scripps Translational Science Center. Articles in this issue include, but are not limited to: Current Transcatheter Approaches for the Treatment of Aortic Coarctation in Children and Adults, Biodegradable Stents for Congenital Heart Disease, State of the Art ASD Closure Devices for Congenital Heart, New PDA Closure Devices and Techniques, Lymphatic Interventions, VSD Closure Devices, Techniques and Outcomes, Pulmonary Artery and Bronchial Stenting: Available Devices, Techniques and Outcomes, and Transcatheter Valve, and Interventions for Adults with Congenital Heart Disease.